Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132711) titled 'Study on the Efficacy of Ganagliflozin Proline Tablets in Subjects with Type 2 Diabetes Mellitus or Prediabetes Accompanied by Carotid Artery Plaque' on Sept. 17.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The Second Afliated Hospital Zhejiang University School of Medicine

Condition: type 2 diabetes or prediabetes accompanied by carotid atherosclerotic plaques

Intervention: Experimental group:Ganagliflozin Proline Tablets plus lifestyle intervention

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-10-01

Target Sample Size: Experimental group:3...